BU PODCAST HAKKINDA 🔗
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Sunucular:
Güncelleme sıklığı:
semiweekly
Ortalama ses uzunluğu:
33 minutes
Sponsorları var
ingilizce
Amerika Birleşik Devletleri
634 bölüm
28 Haziran 2019beri
episodic
AUDIENCE OF THIS PODCAST 🔗
~64.60% of listeners are from India.
🇮🇳
IN
64.60%
🇺🇸
US
28.35%
🇩🇪
DE
1.70%
🇦🇺
AU
1.27%
🇦🇷
AR
0.63%
🇨🇦
CA
0.63%
🇬🇧
GB
0.42%
🇦🇪
AE
0.42%
🇵🇭
PH
0.42%
🇩🇰
DK
0.21%
🇪🇬
EG
0.21%
🇹🇿
TZ
0.21%
🇹🇼
TW
0.21%
🇸🇦
SA
0.21%
🇨🇱
CL
0.21%
🇩🇿
DZ
0.21%
Others
0.09%
* Data source: directly measured on Listen Notes. gerçek zamanlı
SON ÇIKAN BÖLÜM 🔗
How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice?
Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/european-alzheimer…
SON BÖLÜMLERİ ARA
Keeping Current için geçmiş bölümleri ara.
ÖNCEKİ BÖLÜMLER 🔗
Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM.
Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarti…
A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening?
Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-20…
Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression.
Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga-ne…
ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready?
Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-therap…
Do you know who to test, when to test, and which biomarker test to use?
Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_podca…
Do you know how to meet the challenges of treating uveitic macular edema?
Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podcast_…
Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management.
Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-outco…
How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more.
Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-…
Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases?
Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan Medscape Podcasts'e aittir.
PODCAST ARAMA MOTORU
3,828,979podcast'lerini ve196,527,416bölümlerini kişilere, yerlere veya konulara göre aramak için web sitemizi kullanabilirsiniz.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
SON BÖLÜMLERİ ARA
Keeping Current için geçmiş bölümleri ara.
BU PODCAST'İ İSTE
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post seri ilanlar for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
podcast yayıncısı röportajı...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
resmî X (eski adıyla Twitter) hesabımız will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
